1. Home
  2. XBIO vs FCUV Comparison

XBIO vs FCUV Comparison

Compare XBIO & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$2.76

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Logo Focus Universal Inc.

FCUV

Focus Universal Inc.

HOLD

Current Price

$4.00

Market Cap

5.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIO
FCUV
Founded
N/A
2012
Country
United States
United States
Employees
2
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
5.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
XBIO
FCUV
Price
$2.76
$4.00
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
23.1K
20.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$398,137.00
Revenue This Year
$1.99
N/A
Revenue Next Year
$20.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$0.50
52 Week High
$13.93
$12.83

Technical Indicators

Market Signals
Indicator
XBIO
FCUV
Relative Strength Index (RSI) 63.54 47.58
Support Level $2.59 $3.32
Resistance Level $3.21 $4.11
Average True Range (ATR) 0.18 0.51
MACD 0.04 -0.24
Stochastic Oscillator 79.64 10.44

Price Performance

Historical Comparison
XBIO
FCUV

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

Share on Social Networks: